EMOttawa Blog
  • Ottawa Handbook of Emergency Medicine
  • EMOttawa Podcast
  • Point-of-Care Echo
  • Grand Round Summaries
  • Journal Club
  • Commentary
  • Ultrasound
  • Infographics
  • Canadian TIA Score
  • EDI
  • Prehospital and Transport Medicine
  • Ottawa Acute Care Resources
  • About Us
Select Page
Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial

Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial

by Hans Rosenberg | Mar 1, 2021 | Chronic Pain, Journal Club

Methodology: 3.5/5 Usefulness: 3/5 Ruberto AJ, et al. Ann Emerg Med. 2020 Nov 5:S0196-0644(20)30666-1 Question and Methods: Randomized control trial in which cannabis users with active emesis received either haloperidol (0.05mg/kg or 0.1 mg/kg IV) or ondansetron 8mg...
Hyoscine butylbromide versus acetaminophen for nonspecific colicky abdominal pain in children: a randomized controlled trial

Hyoscine butylbromide versus acetaminophen for nonspecific colicky abdominal pain in children: a randomized controlled trial

by Hans Rosenberg | Jan 25, 2021 | Chronic Pain, Full Article, Gastroenterology, Journal Club

Methodology: 4/5 Usefulness: 1/5 Poonai N, et al. CMAJ. 2020 Nov 30;192(48):E1612-E1619. Question and Methods: Randomized control trial assessing effect of hyoscine butylbromide (HBB) vs acetaminophen in nonspecific colicky pain in pediatric patients aged 8-17yo....
  • Facebook
  • Twitter
  • Instagram
  • YouTube

Mission Statement

World-Class Emergency Medicine: To provide outstanding compassionate emergency care through practice-changing research and innovative medical education. For more about our department, visit us at EMOttawa.

Categories

Free Open Access Medical Education content by EMOttawa is under a Creative Commons Attribution-NonCommercial ShareAlike 4.0 International License.